Aurobindo Pharma LimitedEigentümerstruktur
| Preis (2025-07-29) | 52W Hoch | 52W Tief |
| 1158.1 INR | 1.592 INR | 1.010 INR |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| - INR | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 580.801.984 | - | - |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Aurobindo Pharma Limited
Mitarbeiter 0
Handelsplatz NSE
Ticker Symbol AUROPHARMA
IPO Datum -
Adresse Galaxy, Plot No. 1, Hyderabad, India, 500032
Webseite https://www.aurobindo.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Kambam Nithyananda Reddy | Vice Chairman & MD |
| 2 | Mr. Mettu Madan Mohan Reddy | Whole-Time Director |
| 3 | Dr. Makkapati Satakarni B.E., M.B.A., Ph.D. | President of Biologics, CEO of Biologics, Vaccines and Peptid & Director |
| 4 | Mr. Santhanam Subramanian | Chief Financial Officer |
| 5 | Dr. S. Vijaya Kumar | President of Technical |
| 6 | Mr. B. Adi Reddy | Compliance Officer & Company Secretary |
| 7 | Mr. G. P. Prasad | Senior Vice President of Global Finance & Operations |
| 8 | Dr. Sudhir Bimal Singhi | Head of Global Finance Operations |
| 9 | Dr. A. Rama Mohana Rao | Chief Quality Officer -Corporate QA |
| 10 | Dr. V. K. Handa | President of Chemical Research |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
Für dieses Unternehmen liegen derzeit keine Daten zu institutionellen Investoren vor.